Home / IP

Legal News

Coronavirus (COVID-19)—IPO further extends interrupted days

Copyright © 2025 LexisNexis
Published on: 01 June 2020
Published by LNB News

LNB News 01/06/2020

Document Information

Issue Date: 01 June 2020

Published Date: 01 June 2020

Jurisdiction(s): England, Northern Ireland, Scotland and Wales

Article summary

The UK Intellectual property office (IPO) has reviewed its decision in relation to 'interrupted days' due to the coronavirus (COVID-19) pandemic. It has decided to continue with the period of interruption. The next update will be on 22 June 2020. The IPO will give customers advance notice (at least two weeks) to plan prior to the end of interrupted days.​

Powered by Lexis+®
Jurisdiction(s):
England, Northern Ireland, Scotland and Wales

Related documents:

4 News
View More
5 Practice notes
View More
3 Q&As
View More
Powered by Lexis+®

Related documents:

4 News
View More
5 Practice notes
View More
3 Q&As
View More

Popular documents

Priority between loss reliefs in loss making companies

Priority between loss reliefs in loss making companiesWhy does it matter?A company that is a member of a group and has incurred any of the types of losses available for surrender by way of group relief may, without any further rules, have more than one way in which to use the loss. There are a

What is the difference between an appeal and a review?

What is the difference between an appeal and a review?What is an appeal?An appeal in insolvency proceedings is no different to an appeal in normal litigation. An appeal will be allowed only if the appeal court is satisfied that the decision of the lower court was 'wrong' or 'unjust because of a

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of